Vifor Fresenius Medical Care Renal Pharma France
4 products tracked · names used in filings: Vifor Fresenius Medical Care Renal Pharma France
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Kapruvia difelikefalin | Authorised | 2022-04-25 |
| 🇪🇺 | Tavneos avacopan | Revoked | 2022-01-11 |
| 🇪🇺 | Veltassa patiromer | Authorised | 2017-07-19 |
| 🇪🇺 | Velphoro sucroferric oxyhydroxide | Authorised | 2014-08-26 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.